tiprankstipranks
Trending News
More News >
Avalo Therapeutics (AVTX)
NASDAQ:AVTX

Compare Avalo Therapeutics (AVTX) vs. Competitors

Compare
1,037 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Avalo Therapeutics
$16.06
$297.31M
-1.71
86.19%
3 Buy
0 Hold
0 Sell
Strong Buy
Corbus Pharmaceuticals
$8.70
$166.75M
-1.58
-11.94%
7 Buy
0 Hold
0 Sell
Strong Buy
Forte Biosciences
$29.85
$445.08M
-6.72
100.34%
2 Buy
0 Hold
0 Sell
Moderate Buy
Milestone Pharmaceuticals
$2.01
$171.19M
-2.25
-2.02%
3 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$8.45
$147.79M
-2.41
-3.65%
2 Buy
0 Hold
0 Sell
Moderate Buy
Fractyl Health, Inc.
$1.83
$290.53M
-0.81
-8.04%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AVTX
Avalo Therapeutics
14.97
7.07
89.49%
CRBP
Corbus Pharmaceuticals
8.70
-1.20
-12.12%
FBRX
Forte Biosciences
29.85
13.89
87.03%
MIST
Milestone Pharmaceuticals
1.94
-0.08
-3.96%
ELTX
Elicio Therapeutics
8.19
-1.23
-13.06%
GUTS
Fractyl Health, Inc.
1.83
-0.11
-5.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts